Appointments at CMC Biologics, PharmaNet and AAIPharma – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Cmc biologics Management occupations

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at CMC Biologics, PharmaNet and AAIPharma.

Claes Glassell​ has been recruited as CEO of CMC Biologics​. Glassell joined the CMC board in 2005 and has stepped down as CEO of Cerus to take the new role. Earlier in his career Cerus worked at Cambrex, Akzo Nobel and Berol Kemi AB.

eResearchTechnology ​(ERT​) has promoted Jeffrey Litwin​ to CEO, president and member of its board of directors. Litwin joined ERT in 2000 after working at Executive Health Group for seven years.

Valerie Palumbo​ has been named as senior vice president (SVP), corporate quality assurance at PharmaNet Development Group​. Palumbo has more than 20 years of experience developing quality assurance programmes in the drug and medical device sectors.

AAIPharma Services​ has appointed Paul Maffuid​ as EVP of operations. Maffuid has worked in biopharm for 27 years, holding positions at Biopharmalogics, Arena Pharmaceuticals and Magellan Laboratories.

Kevin Cain​ has joined MedPanel​ as VP of business development. In this role Cain will work to increase business from biotech and pharma clients. Cain has previously worked at Serono, Proleon Therapeutics and Millennium Pharmaceuticals.

Intrexon​ has hired Thomas Kasser​ to lead its new animal science division. Kasser is a former Covance CVP and general manager and will now work as division president and SVP of Intrexon.

Former inVentiv Health president Terry Herring​ has joined the advisory board at Archway​, a marketing company. Herring is currently president of commercial operartions at Mission Pharmacal and has also worked at Noven, Solvay and Ciba-Geigy.

Intralinks​ has named Chris Scalet​, chief information officer at Merck & Co, as a member of its board of directors. Scalet joined Merck in 2003. Intralinks provides software-as-a-service systems to biopharm and other industries.

Related topics Markets & Regulations

Related news

Show more